During the past decade, Centro de Investigacion Ricardo Palma conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Centro de Investigacion Ricardo Palma" are "Asthma" (2 trials), "Evaluate the Safety and Efficacy of Denosumab in Pediatric Subjects With" (1 trials) and "Glucocorticoid-induced Osteoporosis" (1 trials). Many other conditions were trialed in "Centro de Investigacion Ricardo Palma" in a lesser frequency.

Most popular intervention types in "Centro de Investigacion Ricardo Palma" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Lebrikizumab" (2 trials), "Denosumab" (1 trials) and "Standard of Care" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centro de Investigacion Ricardo Palma" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Centro de Investigacion Ricardo Palma". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Centro de Investigacion Ricardo Palma, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centro de Investigacion Ricardo Palma, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".